Insights

Blog

Evolution v. Revolution: The Impact of ‘Most Favored Nation’ Pricing

May 23, 2025

By: Annie Scolamieri, Aditi Doshi, Pamela Engelhart, Gregory Lief, and Yakir Siegal

The past few months have been marked by a flurry of announcements and sweeping policy proposals from the...

Continue Reading

Recognizing Mental Health Awareness Month

May 16, 2025

By: Courtney McGee, Nolan Webb, Gregory Lief, and Yakir Siegal

May marks Mental Health Awareness Month, a time dedicated to supporting mental well-being while promoting advocacy, policy, and...

Continue Reading

Better Decisions, Stronger Teams: The Power of Breaking Down Bias

April 2, 2025

By: Aditi Doshi

Unconscious bias is a natural byproduct of how our brains process the world. But just because it’s natural...

Continue Reading

The Future of Biopharma: Reflections on MassBio’s State of Possible 2025 Conference

March 28, 2025

By: Gregory Lief, Yakir Siegal, and Vivian Chen

Three weeks ago, we shared our perspective on the national trends and policies creating swirl in the biopharma...

Continue Reading

Reflections on the Simmons Leadership Conference 2025

March 27, 2025

By: Rachel Sachs, Courtney McGee, Nellie Stidham, Jenna Charles Carson, Aditi Doshi, and Michael Nguyen

Last week, six of our Asymmetry team members attended the Simmons Leadership Conference, an empowering one-day event hosted...

Continue Reading

Addressing Rare Disease Care Pathways

February 26, 2025

By: Aditi Doshi, Pamela Engelhart, Annie Scolamieri, Gregory Lief, and Yakir Siegal

Addressing Rare Disease Care Pathways It’s no secret that we’ve seen incredible innovation in effective treatments for rare...

Continue Reading

Navigating Policy Whiplash: Implications for Biopharma

February 18, 2025

By: Pamela Engelhart, Aditi Doshi, Annie Scolamieri, Yakir Siegal, and Gregory Lief

Navigating Policy Whiplash: Implications for Biopharma The waves are picking up, the surf is churning, and clarity on...

Continue Reading

Reflections on Asymmetry’s 8th Anniversary

January 17, 2025

By: Gregory Lief

It's been 8 years since I founded Asymmetry Group. Time flies and you start thinking you've "seen it...

Continue Reading

Asymmetry Group, LLC Ranks No. 2485 on the 2024 Inc. 5000 List

August 12, 2024

By: Gregory Lief

    For the Second Time, Asymmetry Group Makes the Inc. 5000, at No. 2485 in 2024, With...

Continue Reading

Asymmetry Launches Philanthropy Program, Partners with BHCHP

August 5, 2024

By: Gregory Lief

Asymmetry Launches Philanthropy Program, Partners with BHCHP Asymmetry Group, LLC AIMs (Action with Impact and Meaning) - beyond...

Continue Reading

Insights

Blog

Evolution v. Revolution: The Impact of ‘Most Favored Nation’ Pricing

May 23, 2025

By: Annie Scolamieri, Aditi Doshi, Pamela Engelhart, Gregory Lief, and Yakir Siegal

The past few months have been marked by a flurry of announcements and sweeping policy proposals from the...

Continue Reading

Recognizing Mental Health Awareness Month

May 16, 2025

By: Courtney McGee, Nolan Webb, Gregory Lief, and Yakir Siegal

May marks Mental Health Awareness Month, a time dedicated to supporting mental well-being while promoting advocacy, policy, and...

Continue Reading

Better Decisions, Stronger Teams: The Power of Breaking Down Bias

April 2, 2025

By: Aditi Doshi

Unconscious bias is a natural byproduct of how our brains process the world. But just because it’s natural...

Continue Reading

The Future of Biopharma: Reflections on MassBio’s State of Possible 2025 Conference

March 28, 2025

By: Gregory Lief, Yakir Siegal, and Vivian Chen

Three weeks ago, we shared our perspective on the national trends and policies creating swirl in the biopharma...

Continue Reading

Reflections on the Simmons Leadership Conference 2025

March 27, 2025

By: Rachel Sachs, Courtney McGee, Nellie Stidham, Jenna Charles Carson, Aditi Doshi, and Michael Nguyen

Last week, six of our Asymmetry team members attended the Simmons Leadership Conference, an empowering one-day event hosted...

Continue Reading

Addressing Rare Disease Care Pathways

February 26, 2025

By: Aditi Doshi, Pamela Engelhart, Annie Scolamieri, Gregory Lief, and Yakir Siegal

Addressing Rare Disease Care Pathways It’s no secret that we’ve seen incredible innovation in effective treatments for rare...

Continue Reading

Navigating Policy Whiplash: Implications for Biopharma

February 18, 2025

By: Pamela Engelhart, Aditi Doshi, Annie Scolamieri, Yakir Siegal, and Gregory Lief

Navigating Policy Whiplash: Implications for Biopharma The waves are picking up, the surf is churning, and clarity on...

Continue Reading

Reflections on Asymmetry’s 8th Anniversary

January 17, 2025

By: Gregory Lief

It's been 8 years since I founded Asymmetry Group. Time flies and you start thinking you've "seen it...

Continue Reading

Asymmetry Group, LLC Ranks No. 2485 on the 2024 Inc. 5000 List

August 12, 2024

By: Gregory Lief

    For the Second Time, Asymmetry Group Makes the Inc. 5000, at No. 2485 in 2024, With...

Continue Reading

Asymmetry Launches Philanthropy Program, Partners with BHCHP

August 5, 2024

By: Gregory Lief

Asymmetry Launches Philanthropy Program, Partners with BHCHP Asymmetry Group, LLC AIMs (Action with Impact and Meaning) - beyond...

Continue Reading

Insights

Blog

Evolution v. Revolution: The Impact of ‘Most Favored Nation’ Pricing

May 23, 2025

By: Annie Scolamieri, Aditi Doshi, Pamela Engelhart, Gregory Lief, and Yakir Siegal

The past few months have been marked by a flurry of announcements and sweeping policy proposals from the...

Continue Reading

Recognizing Mental Health Awareness Month

May 16, 2025

By: Courtney McGee, Nolan Webb, Gregory Lief, and Yakir Siegal

May marks Mental Health Awareness Month, a time dedicated to supporting mental well-being while promoting advocacy, policy, and...

Continue Reading

Better Decisions, Stronger Teams: The Power of Breaking Down Bias

April 2, 2025

By: Aditi Doshi

Unconscious bias is a natural byproduct of how our brains process the world. But just because it’s natural...

Continue Reading

The Future of Biopharma: Reflections on MassBio’s State of Possible 2025 Conference

March 28, 2025

By: Gregory Lief, Yakir Siegal, and Vivian Chen

Three weeks ago, we shared our perspective on the national trends and policies creating swirl in the biopharma...

Continue Reading

Reflections on the Simmons Leadership Conference 2025

March 27, 2025

By: Rachel Sachs, Courtney McGee, Nellie Stidham, Jenna Charles Carson, Aditi Doshi, and Michael Nguyen

Last week, six of our Asymmetry team members attended the Simmons Leadership Conference, an empowering one-day event hosted...

Continue Reading

Addressing Rare Disease Care Pathways

February 26, 2025

By: Aditi Doshi, Pamela Engelhart, Annie Scolamieri, Gregory Lief, and Yakir Siegal

Addressing Rare Disease Care Pathways It’s no secret that we’ve seen incredible innovation in effective treatments for rare...

Continue Reading

Navigating Policy Whiplash: Implications for Biopharma

February 18, 2025

By: Pamela Engelhart, Aditi Doshi, Annie Scolamieri, Yakir Siegal, and Gregory Lief

Navigating Policy Whiplash: Implications for Biopharma The waves are picking up, the surf is churning, and clarity on...

Continue Reading

Reflections on Asymmetry’s 8th Anniversary

January 17, 2025

By: Gregory Lief

It's been 8 years since I founded Asymmetry Group. Time flies and you start thinking you've "seen it...

Continue Reading

Asymmetry Group, LLC Ranks No. 2485 on the 2024 Inc. 5000 List

August 12, 2024

By: Gregory Lief

    For the Second Time, Asymmetry Group Makes the Inc. 5000, at No. 2485 in 2024, With...

Continue Reading

Asymmetry Launches Philanthropy Program, Partners with BHCHP

August 5, 2024

By: Gregory Lief

Asymmetry Launches Philanthropy Program, Partners with BHCHP Asymmetry Group, LLC AIMs (Action with Impact and Meaning) - beyond...

Continue Reading